Johnson Investment Counsel Inc Pfizer Inc Transaction History

Johnson Investment Counsel Inc

$10.1 Billion
Q3 2024

A detailed history of Johnson Investment Counsel Inc transactions in Pfizer Inc stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 131,902 shares of PFE stock, worth $3.48 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

131,902

Previous 130,463 1.1%

Holding current value

$3.48 Million

Previous $3.65 Million 4.58%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$27.7 - $31.39 $39,860 - $45,170	1,439 Added 1.1%	131,902 $3.82 Million
Q2 2024 Aug 08, 2024	SELL	$25.26 - $29.6 $184,170 - $215,813	-7,291 Reduced 5.29%	130,463 $3.65 Million
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $156,323 - $179,509	-6,038 Reduced 4.2%	137,754 $3.82 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $458,424 - $595,443	-17,544 Reduced 10.87%	143,792 $4.14 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $316,503 - $369,961	9,863 Added 6.51%	161,336 $5.35 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $336,566 - $389,399	-9,318 Reduced 5.8%	151,473 $5.56 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $1.75 Million - $2.28 Million	-44,483 Reduced 21.67%	160,791 $6.56 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $52,605 - $68,670	1,260 Added 0.62%	205,274 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $348,898 - $425,917	-7,973 Reduced 3.76%	204,014 $8.93 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1.02 Million - $1.21 Million	21,964 Added 11.56%	211,987 $11.1 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $317,642 - $393,598	-6,943 Reduced 3.52%	190,023 $9.84 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $344,939 - $511,315	-8,348 Reduced 4.07%	196,966 $11.6 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $805,017 - $1.03 Million	20,510 Added 11.1%	205,314 $8.83 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $22,156 - $25,099	-617 Reduced 0.33%	184,804 $7.24 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $123,645 - $139,446	3,692 Added 2.03%	185,421 $6.72 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $33,838 - $43,028	-1,011 Reduced 0.55%	181,729 $6.69 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $8,318 - $9,759	-262 Reduced 0.14%	182,740 $6.71 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $144,455 - $175,245	-4,796 Reduced 2.55%	183,002 $5.98 Million
Q1 2020 May 20, 2020	SELL	$27.03 - $38.62 $33,138 - $47,348	-1,226 Reduced 0.65%	187,798 $6.13 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $304,707 - $345,804	-9,256 Reduced 4.67%	189,024 $7.41 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $1.22 Million - $1.58 Million	37,508 Added 23.33%	198,280 $7.12 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $28,585 - $32,094	773 Added 0.48%	160,772 $6.96 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $301,087 - $330,794	-8,029 Reduced 4.78%	159,999 $6.8 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $270,174 - $308,028	7,023 Added 4.36%	168,028 $7.33 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $127,435 - $154,571	3,697 Added 2.35%	161,005 $7.1 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $130,270 - $138,882	-3,950 Reduced 2.45%	157,308 $5.71 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $5,743 - $6,663	-180 Reduced 0.11%	161,258 $5.72 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $54,180 - $57,487	1,629 Added 1.02%	161,438 $5.85 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $4.95 Million - $5.46 Million	159,809	159,809 $5.71 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Account

Johnson Investment Counsel Inc Pfizer Inc Transaction History